Celgene's New Regime: Hugin And Alles Discuss Handing Over The Reins
This article was originally published in Scrip
Mark Alles has been in his first pharma chief executive role for six weeks, after stepping into former Celgene Corp. leader Bob Hugin's shoes in March. While Alles has been with the company for 12 years and in the pharma industry for three decades he brings new skills to the top spot at Celgene and a keen eye for keeping science at the fore of his corporate decision making.
Register for our free email digests: